Home › Funds › BERKSHIRE ASSET MANAGEMENT LLC/PA › ABT

BERKSHIRE ASSET MANAGEMENT LLC/PA position in ABT

ABBOTT LABORATORIES · Health Care

BERKSHIRE ASSET MANAGEMENT LLC/PA reported holding 316,613 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$31.3M, representing 1.31% of its reported portfolio and ranking #28 among its reported holdings. BERKSHIRE ASSET MANAGEMENT LLC/PA has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)316.61K sh
Reported value held$31.29M
Portfolio Weight1.31%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BERKSHIRE ASSET MANAGEMENT LLC/PA's ABT position evolved

BERKSHIRE ASSET MANAGEMENT LLC/PA first disclosed a stake in ABT in Q3 2023 at 288,897 shares (US$28.0M). The position peaked in Q2 2025 at 307,278 shares, worth US$41.8M. Across 13 filings, BERKSHIRE ASSET MANAGEMENT LLC/PA increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 316,613 shares valued at US$31.3M — an increase of 3,394 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 288.90K $27.98M New
Q4 2023 287.90K $31.69M Hold
Q1 2024 288.70K $32.81M Hold
Q2 2024 306.13K $31.81M Add
Q3 2024 306.13K $31.81M Hold
Q4 2024 304.65K $38.09M Hold
Q1 2025 308.39K $41.32M Add
Q2 2025 307.28K $41.79M Hold
Q3 2025 305.45K $40.91M Reduce
Q4 2025 301.07K $37.72M Reduce
Q1 2026 306.71K $31.49M Add
Q2 2026 313.22K $28.42M Add
Q3 2026 316.61K $31.29M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has BERKSHIRE ASSET MANAGEMENT LLC/PA held ABT?

BERKSHIRE ASSET MANAGEMENT LLC/PA has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BERKSHIRE ASSET MANAGEMENT LLC/PA's current position in ABT?

As of Q3 2026, BERKSHIRE ASSET MANAGEMENT LLC/PA holds 316.61K shares of ABT (ABBOTT LABORATORIES), valued at $31.29M, representing 1.31% of its reported portfolio and ranking #28.

Has BERKSHIRE ASSET MANAGEMENT LLC/PA been buying or selling ABT?

In the latest 13F filing (Q3 2026), BERKSHIRE ASSET MANAGEMENT LLC/PA increased its position in ABT. The position peaked in Q2 2025 at 307.28K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.